United States (U.S.) HIV specialist pharmaceutical company, ViiV Healthcare on Wednesday said that the U.S. Food and Drug Administration (FDA) has approved Cabenuva cabotegravir and rilpivirine for
By Chioma Obinagwam with Agency Report The man in Britain is the treatment’s second worldwide success after a US man known as the “Berlin patient” 12 years